Regencell Bioscience Holdings Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +27.6% | -18.7% | -0.3% | -21.2% | +163.2% | -66.3% | +52.1% | -36.9% | +36.1% | -1.8% | +0.1% | +0.6% | +24.4% | -5.5% | -0.1% | -100.1% | – | – | – | – | – | – | |
| – | +17.9% | +10.1% | +14.4% | -1.0% | -7.1% | +10.4% | 0.0% | +12.0% | -10.8% | -7.7% | +9.8% | +3.7% | +2.3% | +6.4% | +10.4% | -100.0% | +0.0% | +178.0% | +2,184.5% | +27.3% | -3.1% | -47.3% | |
| – | +150.0% | +0.0% | +0.0% | +60.0% | -37.5% | +0.0% | +18.0% | +42.4% | -6.0% | +30.4% | -9.7% | +1.1% | -11.7% | +6.0% | +4.5% | – | – | – | – | -66.3% | -51.7% | -45.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | -5.4% | – | – | – | |
| – | +325.0% | -50.9% | +75.2% | -133.7% | – | -133.9% | – | -215.6% | – | – | – | – | – | -289.9% | – | – | – | +624.9% | -285.2% | – | – | – | |
| – | – | – | – | – | – | – | – | -9.6% | -11.4% | +2.3% | +25.7% | +39.9% | +18.4% | +15.7% | +16.5% | -100.0% | +0.0% | -100.0% | +78,087,500.0% | -96.5% | -80.4% | +2,740.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +9,049.0% | 0.0% | – | +8,789.1% | -48.8% | |
| – | +4,105.3% | – | – | +2.3% | +170.9% | – | – | +195.2% | -60.3% | +121.3% | -54.0% | +123.0% | -52.8% | -0.1% | +0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +51,225.0% | +23.2% | -56.7% | +156.5% | -47.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +105.4% | -38.1% | -170.6% | -100.0% | – | – | |
| – | +462.0% | – | – | -2.6% | +158.1% | – | – | +110.3% | -31.8% | +50.1% | – | -499.5% | -46.3% | -10.4% | -89.4% | – | +105.4% | -55.5% | +4,995.1% | -99.4% | -24.2% | – | |
| – | -94.2% | +575.0% | -158.0% | – | – | -124.9% | – | -177.8% | – | -399.0% | – | -177.3% | – | -62.9% | -165.8% | – | +59.6% | -328.0% | – | -176.3% | – | -138.8% | |
| – | +27.6% | -18.7% | -0.3% | -21.2% | +163.2% | -66.3% | +11.9% | -46.7% | +65.2% | -3.2% | -8.8% | -18.1% | +29.3% | -21.4% | -18.5% | -100.2% | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.